RPG Life Sciences share news, announcements and annual reports
NSE: RPGLIFEBSE: 532983Pharmaceuticals & BiotechnologySmall Cap
RPG Life Sciences Limited · Face value ₹8 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Jun 2008
Last close ₹2,575.70down ₹428.10 (14.25%)BSE ₹2,572.40
Share price at the NSE close on 30 Oct 2026. Previous close ₹3,003.80.
30 Oct: open ₹2,812.00, high ₹2,849.60, low ₹2,513.50
52-week range of traded prices to 30 Oct 2026
₹1,733.00Low, 23 Mar 2026₹3,127.80High, 25 Sep 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹4,260 Cr923rd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 38.94
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 6.20
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.93%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it, the company's own balance sheet from before it began consolidating; the two agree where both are first on record.
- 17.6%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 14.9%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026.
- 0.03
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 1,38,78323.6% delivered
RPG Life Sciences results
74 filed, newest first. Page 2 of 2.
Oct 2015
Jul 2015
Apr 2015
29 Apr · Results
Jan 2015
Oct 2014
Jul 2014
24 Jul · Results
Apr 2014
30 Apr · Results
Feb 2014
Oct 2013
18 Oct · Results
Jul 2013
May 2013
Feb 2013
Oct 2012
Aug 2012
Apr 2012
27 Apr · Results
Jan 2012
Oct 2011
Jul 2011
28 Jul · Results
Apr 2011
28 Apr · Results
15 Apr · Results
Company would be submitting the audited financial results for the year ended March 31, 2011 within 60 days from the end of financial year. In view of this, the Company will not be submitting / publish the unaudited financial results for the last quarter ended March 31, 2011.
Jan 2011
Oct 2010
Apr 2009
8 Apr · Results
Company would be submitting the audited financial results for the year ended March 31, 2009 within 3 months from the end of financial year. In view of this, the Company will not be submitting / publish the unaudited financial results for the last quarter ended March 31, 2009.
Mar 2009
27 Mar · Results
In terms of the resolution passed by the Board of Directors on February 20, 2009, the Company conducted the postal ballot under Section 192A of the Companies Act, 1956 read with the Companies (Passing of Resolution by the Postal Ballot) Rules, 2001 in respect of Special Resolution under Section 81(1A) of the Companies Act, 1956 for issue and allotment of 15,00,000 convertible warrants to Petrochem International Limited and 6,38,000 convertible warrants to KEC Holdings Limited, both Promoter Group Companies, on preferential basis, in accordance with SEBI Guidelines for Preferential Issues. The above resolution is approved by the shareholders by requisite majority. A copy of the result of postal ballot shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements) For more details click here.